Antivenom Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029

The Business Research Company’s Antivenom Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- What Is The Estimated Industry Size Of Antivenom Market?
The size of the antivenom market has seen significant expansion in the last few years. Its growth is forecasted to increase from $1.92 billion in 2024 to $2.04 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. The previous period witnessed growth due to factors such as the high rate of snakebites, the geographical spread of venomous snakes, restricted access to healthcare services, farming and rural operations, and initiatives in public health.
The antivenom market is set to experience substantial growth in the upcoming years, anticipated to reach a value of ""$2.69 billion in 2029 with a compound annual growth rate (CAGR) of 7.2%. The increase during this forecast period can be linked to the effects of climate change on snake environments, the rise in population in regions susceptible to snakes, progression in antivenom formulation, worldwide health security initiatives, and combined endeavors for antivenom production. Key trends projected for this period include the incorporation of data analytics, emphasis on education and training, strategic partnerships for enhancing production, improvements in the regulatory structure, and research into innovative therapeutic targets.
Download a free sample of the antivenom market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10798&type=smp
What Are The Major Factors Driving The Antivenom Global Market Growth?
The antivenom market's growth is set to be fueled by the increasing number of snake bites. Snake bites can be fatal due to the toxins released into the victim's bloodstream. A specialized remedy, antivenom, can potentially mitigate or even negate the majority of snakebite envenoming symptoms if given promptly and in the right dosage. The World Health Organization (WHO), a public health agency based in Switzerland under the United Nations, reported in September 2023 that globally, around 5.4 million people suffer snake bites annually, leading to 1.8 to 2.7 million instances of envenoming. Each year, snake bites claim the lives of about 81,410 to 137,880 individuals. The goal is to cut snakebite envenoming-related mortality and disability rates by half by 2030. Consequently, the escalating incidence of snake bites is propelling the antivenom market's expansion.
Who Are The Leading Companies In The Antivenom Market?
Major players in the Antivenom include:
• Pfizer Inc.
• Commonwealth Serum Laboratories
• Merck KGaA
• Incepta Pharmaceuticals Limited
• Bharat Serums and Vaccines Limited
• Rare Disease Therapeutics Inc.
• Vins Bioproducts Limited
• Boehringer Ingelheim International GmbH
• Boston Scientific Corporation
• Haffkine Bio-Pharmaceutical Corporation Limited
What Are The Prominent Trends In The Antivenom Market?
Leading businesses in the antivenom market are embracing innovative technology like public-benefit target products to bolster the performance, safety, and availability of antivenoms. The ultimate goal is to better patient outcomes and lessen the worldwide impact of snakebite envenomation. Public-benefit target products refer to healthcare advancements or medical supplies created primarily to meet specific public health requirements, especially among underprivileged or vulnerable groups. For example, in June 2023, Bharat Serums and Vaccines Ltd., a US-based biotech firm, partnered with the Indian Institute of Science, an Indian public institution, to create antivenoms tailored for snakebites in India. The partnership's objective is to boost the effectiveness of treatments and minimize the public health stress of snakebites in impacted areas.
What Are The Primary Segments Covered In The Global Antivenom Market Report?
The antivenom market covered in this report is segmented –
1) By Type: Monovalent, Polyvalent, Other Types
2) By Animal: Snakes, Scorpions, Spiders, Other Animals
3) By Mode of Action: Cytotoxic, Neurotoxic, Hemotoxic, Cardiotoxic, Myotoxic, Other Modes Of Action
4) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Monovalent: Specific Antivenoms For Individual Snake Species, Specific Antivenoms For Individual Venom Types
2) By Polyvalent: Broad-Spectrum Antivenoms, Regional Polyvalent Antivenoms
3) By Other Types: Antivenoms For Other Venoms, Recombinant Antivenoms, Antivenom For Rare Venoms
View the full antivenom market report:
https://www.thebusinessresearchcompany.com/report/antivenom-global-market-report
Which Region Is Forecasted To Grow The Fastest In The Antivenom Industry?
In 2024, North America dominated the antivenom global market. During the forecast period, however, Asia-Pacific is anticipated to exhibit the most rapid growth. The antivenom market report includes regions such as Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Browse Through More Reports Similar to the Global Antivenom Market 2025, By The Business Research Company
Arthritis Monoclonal Antibodie Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/arthritis-monoclonal-antibodie-global-market-report
Biosimilar Monoclonal Antibodie Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biosimilar-monoclonal-antibodie-global-market-report
Breast Cancer Monoclonal Antibodie Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/breast-cancer-monoclonal-antibodie-global-market-report
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: [email protected]
The Business Research Company - www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Oliver Guirdham
The Business Research Company
+44 7882 955267
[email protected]
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]
